Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Liaoning Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 31 active clinical trials for multiple myeloma hosted across 7 tertiary medical centers in Liaoning (including Shengjing Hospital of China Medical University, The First Hospital of China Medical University, Zhongshan Hospital Affiliated to Dalian University, etc.).
Participating Medical Centers (7)
Active Studies in Liaoning (31)
Population synthesized by CMDNShowing 0 published English records of 31 registry trials.
All 31 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.